To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Opened position in Kymera Therapeutics, Inc. by 19,637 shares and now represents 0.095% of the total position.
      125Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 154,988 shares, the number of shares held decreased 1.04% compared to the previous period and now represents 3.1% of the total position.
      230Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 5,615 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 1.84% of the total position.
      21Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 76,843 shares, the number of shares held decreased 1.51% compared to the previous period and now represents 1.99% of the total position.
      59Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 1,014 shares, the number of shares held decreased 1.5% compared to the previous period and now represents 3.52% of the total position.
      11Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 165,724 shares, the number of shares held decreased 1.51% compared to the previous period and now represents 5.06% of the total position.
      63Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 8,060 shares, the number of shares held decreased 1.51% compared to the previous period and now represents 1.72% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 28,587 shares, the number of shares held decreased 1.51% compared to the previous period and now represents 2.29% of the total position.
      115Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 171,236 shares, the number of shares held decreased 1.51% compared to the previous period and now represents 1.38% of the total position.
      4.73K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-09 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 371,231 shares, the number of shares held increased 30.65% compared to the previous period and now represents 3.22% of the total position.
      10Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed